Jefferies Financial Group’s MacroGenics MGNX Stock Holding History

Jefferies Financial Group’s Portfolio MGNX Stock Details MGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-1,841,172	Closed	-$2.96M	–	2033
2025 Q4	$2.96M	Buy	+1,841,172	New	+$2.89M	0.02%	649
2024 Q4	–	Sell	-3,135	Closed	-$10.3K	–	1734
2024 Q3	$10.3K	Sell	3,135 -21,865	-87%	-$85.2K	﹤0.01%	1383
2024 Q2	$106K	Buy	+25,000	New	+$243K	﹤0.01%	1283

Other funds holding MGNX

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Jefferies Financial Group's MGNX Position: Q1 2026 in Review

Jefferies Financial Group sold out of MacroGenics (MGNX) in Q1 2026, closing a stake of 1,841,172 shares — an estimated $2.96M sold.

Jefferies Financial Group first reported a position in MGNX in Q2 2024 and held it in 3 quarters. The position peaked at $2.96M in Q4 2025. 109 funds tracked by Wall St. Rank hold MGNX as of Q1 2026.

Jefferies Financial Group reported no remaining MacroGenics position as of Q1 2026 after selling out during the quarter.
Jefferies Financial Group sold 1,841,172 MacroGenics shares in Q1 2026, an estimated $2.96M.
Jefferies Financial Group first reported a position in MacroGenics in Q2 2024 and held it in 3 quarters.
Jefferies Financial Group's MacroGenics position peaked at $2.96M in Q4 2025.
109 funds tracked by Wall St. Rank held MacroGenics as of Q1 2026.

Based on Jefferies Financial Group's 13F filing for Q1 2026, filed 8 May 2026.